Voyager Therapeutics (VYGR) Competitor Comparison
We are evaluating the key criteria listed to compare Voyager Therapeutics (VYGR) against its competitors in the Biotechnology industry.
Market Capitalization
170 / 368Gross Profits
172 / 278Total Revenue
70 / 300EBITDA
22 / 337Free Cashflow
23 / 352Quick Ratio
210 / 357Earnings per Share
32 / 359Dividend yield
0 / 6Total Cash
130 / 358Performance 3 years
47 / 368Performance 5 years
182 / 368Performance 10 years
157 / 368Linearity 3 years
124 / 368Linearity 5 years
118 / 368Linearity 10 years
112 / 368Total Rank
63 / 368Dividend Rank
308 / 368Valuation Rank
55 / 368Piotroski Rank
324 / 368Muliplier Rank
119 / 368Gross Profits - VYGR ranking 172 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.